Prevalence of ENT Diseseas

Trial Title: Prevalence of ENT Diseseas

NCT ID: NCT06105346

Condition: Conscripts
Military Induction Board
ENT Disease
Rhinosinusitis Chronic
Rhinosinusitis
HPV Infection
HPV Vaccine
Long COVID
ENT Surgery

Conditions: Official terms:
Rhinosinusitis
Sinusitis
Post-Acute COVID-19 Syndrome
Papillomavirus Infections
Otorhinolaryngologic Diseases

Conditions: Keywords:
ENT
prevalence
military induction board
conscripts
rhinosinusitis
Long COVID
ENT surgeries
HPV vaccination
inborn hearing loss

Study type: Observational [Patient Registry]

Overall status: Not yet recruiting

Study design:

Time perspective: Prospective

Summary: The aim of the present study will be to evaluate in conscripts at the military induction board the prevalence of rhinosinusitis, the prevalence of HPV vaccinations, the prevalence of hearing impairments and the prevalence of long-COVID symptoms and further, to evaluate different factors that influence on the one hand the prevalence (urban-bred, non-urban-bred) and on the other hand symptoms (ENT-surgeries in medical history). Further, we want to evaluate if there is a correlation between subjective symptoms and apparated-based diagnostic investigations. Therefore, questionnaires and data of medical examinations, aquired routinely at the military induction board, will be analysed.

Detailed description: Rhinosinusitis is a very common complaint at ENT departments, whereby symptoms of the underlying disease are varying. Therefore, there is growing interest in prevalence of rhinosinusitis including differences in prevalence's depending on where the patient grew up. Further, there is growing interest in answering the question if different factors, including ENT-surgeries in medical history have an impact on symptoms of rhinosinusitis. Within the past few years there is growing interest in carring out as many HPV-vaccinations as possible in order to reduce the prevalence of HPV-associated cancers. Further, in adolescents there is a growing number of hearing impairments, including hearing loss and/or sounds in the ears. Next, since the beginning of the COVID pandemic there are very common complaints in adult and pediatric patients about persistent medical problems for weeks or months after an acute SARS-CoV-2-infection and cannot be explained by another diagnosis, called long- Covid disease. The military induction board of conscripts enables access to data from a cross-section of the population, with common characteristics of gender and age. In the present study we want therefore to evaluate in conscripts at the military induction board the prevalence of rhinosinusitis, the prevalence of HPV vaccinations, the prevalence of hearing impairments and the prevalence of long-COVID symptoms and further, to evaluate different factors that influence on the one hand the prevalence (urban-bred, non-urban-bred) and on the other hand symptoms (ENT-surgeries in medical history). Further, we want to evaluate if there is a correlation between subjective symptoms and apparated-based diagnostic investigations.

Criteria for eligibility:

Study pop:
All male Austrian conscripts who take part at the military inductions board are eligible for the study inclusion.

Sampling method: Probability Sample
Criteria:
Inclusion Criteria: - participation of the military induction board of conscripts - consent for participation obtained by the conscripts - completed questionnaire (with at least 50% completeness of each subcategory) - participation of medical examination Exclusion Criteria: - no consent for participation in the study by the conscripts - incomplete questionnaire (with less than 50% completeness of each subcategory) - no participation of medical examination.

Gender: Male

Gender based: Yes

Gender description: only Austrian males (conscripts), who are invited at the military induction board

Minimum age: 17 Years

Maximum age: 19 Years

Healthy volunteers: Accepts Healthy Volunteers

Start date: December 1, 2023

Completion date: March 31, 2026

Lead sponsor:
Agency: Medical University of Graz
Agency class: Other

Source: Medical University of Graz

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT06105346